Market Overview:
The global acromegaly treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of acromegaly, technological advancements in the field of acromegaly treatment, and rising awareness about acromegaly. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. The global acromegaly treatment market can be segmented on the basis of type into ectopic acromegaly and pseudoacromegaly. The ectopic form is more common than pseudoacromegy and accounts for around 85-90% cases globally. On the basis of application, surgery is currently used as a primary mode for treating most patients with acromegy followed by drug therapy and radiation therapy respectively.
Product Definition:
Acromegaly Treatment is the use of medications or surgery to treat acromegaly. Acromegaly is a condition that results from too much growth hormone (GH) in the body. GH is produced by the pituitary gland and regulates growth and energy levels. When too much GH is produced, it can cause bones to grow too large, especially in the hands, feet, and jaw. It can also lead to heart problems, diabetes, and other health issues. Acromegaly Treatment can help control these symptoms.
Ectopic Acromegaly:
Ectopic acromegaly is a disease in which the abnormal growth of the hands, feet, and face (ectromelia) is caused due to excessive production of Growth Hormone (GH). Ectopic acromegaly can also develop in other areas such as lungs, liver or spleen. The condition affects males and females equally.
Pseudo Acromegaly:
Pseudo acromegaly is a condition, which causes an increase in the growth of non-cancerous tumors along with cancerous tumors. It also causes hormonal imbalance and changes in the shape of hands, feet, face & head. Pseudo acromegaly can be diagnosed through blood tests and imaging techniques such as MRI or CT scan.
Application Insights:
The application segment is sub-divided into surgery, drug therapy, and radiation therapy. Acromegaly treatment includes surgical removal of the tumor as well as medication and radiation therapies for its treatment. The surgery segment dominated the market in 2017 due to availability of advanced techniques such as transnasal skull-based approach for acromegaly diagnosis and deep brain stimulation for treating acromegaly.
However, this approach has been associated with higher mortality rates which may restrict its adoption in future thereby supporting the dominance of surgery over other applications during recent years. Drug therapy is expected to be fastest growing application during forecast period due to increasing number of clinical trials supported by pharmaceutical companies for evaluating new drugs specifically designed against acromegalic tumors that exhibit high unmet medical need across various regions including North America and Europe despite being well tolerated by patients resulting in high demand from end-users especially from healthcare professionals involved directly or indirectly related with their care thus propelling growth during estimated time frame.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario, and increasing healthcare expenditure are some of the factors responsible for its dominance. In addition, growing awareness about acromegaly treatment options is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China & India. Furthermore, an increase in prevalence of diabetes coupled with a rise in cardiovascular diseases (CVDs) has led to an increase demand for endoscopic procedures which will further boost revenue generation from this region over next eight years (from 2018 to 2030). Moreover Acromegaly Treatment Market by Region (North America, Europe), And Drug Class (%) Forecast From 2018 To 2030 The U.S.
Growth Factors:
- Increasing incidence of acromegaly
- Growing awareness about acromegaly and its treatment options
- Rising demand for better and more effective treatments for acromegaly
- Availability of new and innovative therapies for the treatment of acromegaly
- Growing number of clinical studies on the efficacy and safety of various treatments for acromegaly
Scope Of The Report
Report Attributes
Report Details
Report Title
Acromegaly Treatment Market Research Report
By Type
Ectopic Acromegaly, Pseudo Acromegaly
By Application
Surgery, Drug Therapy, Radiation Therapy
By Companies
Pfizer Inc., Chiasma Inc, Novartis AG, Ipsen Biopharmaceuticals Inc, Wockhardt Ltd., Troikaa Pharmaceuticals Limited, VHB Life Sciences Limited, GlaxoSmithKline plc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Acromegaly Treatment Market Report Segments:
The global Acromegaly Treatment market is segmented on the basis of:
Types
Ectopic Acromegaly, Pseudo Acromegaly
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgery, Drug Therapy, Radiation Therapy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer Inc.
- Chiasma Inc
- Novartis AG
- Ipsen Biopharmaceuticals Inc
- Wockhardt Ltd.
- Troikaa Pharmaceuticals Limited
- VHB Life Sciences Limited
- GlaxoSmithKline plc
Highlights of The Acromegaly Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ectopic Acromegaly
- Pseudo Acromegaly
- By Application:
- Surgery
- Drug Therapy
- Radiation Therapy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acromegaly Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acromegaly is a medical condition in which the body produces too much growth hormone. This can cause serious health problems, including obesity, diabetes, heart disease and cancer. Treatment for acromegaly typically includes medications to lower the level of growth hormone in the body and surgery to remove excess tissue from around the brain or neck.
Some of the major players in the acromegaly treatment market are Pfizer Inc., Chiasma Inc, Novartis AG, Ipsen Biopharmaceuticals Inc, Wockhardt Ltd., Troikaa Pharmaceuticals Limited, VHB Life Sciences Limited, GlaxoSmithKline plc.
The acromegaly treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acromegaly Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Acromegaly Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Acromegaly Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Acromegaly Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Acromegaly Treatment Market Size & Forecast, 2018-2028 4.5.1 Acromegaly Treatment Market Size and Y-o-Y Growth 4.5.2 Acromegaly Treatment Market Absolute $ Opportunity
Chapter 5 Global Acromegaly Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acromegaly Treatment Market Size Forecast by Type
5.2.1 Ectopic Acromegaly
5.2.2 Pseudo Acromegaly
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acromegaly Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acromegaly Treatment Market Size Forecast by Applications
6.2.1 Surgery
6.2.2 Drug Therapy
6.2.3 Radiation Therapy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acromegaly Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acromegaly Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acromegaly Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Acromegaly Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acromegaly Treatment Market Size Forecast by Type
9.6.1 Ectopic Acromegaly
9.6.2 Pseudo Acromegaly
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acromegaly Treatment Market Size Forecast by Applications
9.10.1 Surgery
9.10.2 Drug Therapy
9.10.3 Radiation Therapy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acromegaly Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Acromegaly Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acromegaly Treatment Market Size Forecast by Type
10.6.1 Ectopic Acromegaly
10.6.2 Pseudo Acromegaly
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acromegaly Treatment Market Size Forecast by Applications
10.10.1 Surgery
10.10.2 Drug Therapy
10.10.3 Radiation Therapy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acromegaly Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acromegaly Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acromegaly Treatment Market Size Forecast by Type
11.6.1 Ectopic Acromegaly
11.6.2 Pseudo Acromegaly
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acromegaly Treatment Market Size Forecast by Applications
11.10.1 Surgery
11.10.2 Drug Therapy
11.10.3 Radiation Therapy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acromegaly Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Acromegaly Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acromegaly Treatment Market Size Forecast by Type
12.6.1 Ectopic Acromegaly
12.6.2 Pseudo Acromegaly
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acromegaly Treatment Market Size Forecast by Applications
12.10.1 Surgery
12.10.2 Drug Therapy
12.10.3 Radiation Therapy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acromegaly Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acromegaly Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acromegaly Treatment Market Size Forecast by Type
13.6.1 Ectopic Acromegaly
13.6.2 Pseudo Acromegaly
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acromegaly Treatment Market Size Forecast by Applications
13.10.1 Surgery
13.10.2 Drug Therapy
13.10.3 Radiation Therapy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acromegaly Treatment Market: Competitive Dashboard
14.2 Global Acromegaly Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer Inc.
14.3.2 Chiasma Inc
14.3.3 Novartis AG
14.3.4 Ipsen Biopharmaceuticals Inc
14.3.5 Wockhardt Ltd.
14.3.6 Troikaa Pharmaceuticals Limited
14.3.7 VHB Life Sciences Limited
14.3.8 GlaxoSmithKline plc